What We Do

Tiber Creek Partners is multi-faceted resource for businesses interested in a range of biotechnology applications, including emerging infectious diseases, biodefense and bioterrorism, pandemic influenza preparedness, military medicine, regenerative medicine, neglected and tropical diseases, industrial biotechnology, and personalized medicine.

We help our clients meet their business objectives by developing and executing funding strategies for technological advancements in life sciences that create profitable partnerships between the pharmaceutical and biotechnology industries with the financial community, private investors, governments, and non-governmental organizations.

Our team employs a range of business planning and procurement advocacy tools to successfully create markets for biotechnology opportunities of interest to government purchasers such as the Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), the Department of Homeland Security (DHS), the Department of Defense (DoD), the Department of Energy (DOE), the Department of Agriculture (USDA), the European Union (EU) and various defense and health ministries throughout Europe, as well as non-governmental funding enterprises around the globe.